These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 25846395)

  • 1. Diagnostic utility of measuring free light chains in the cerebrospinal fluid of patients with multiple myeloma.
    Marron TU; Ramanathan L; Chari A
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):e127-31. PubMed ID: 25846395
    [No Abstract]   [Full Text] [Related]  

  • 2. Meningeal and cerebral involvement in multiple myeloma patients.
    Patriarca F; Zaja F; Silvestri F; Sperotto A; Scalise A; Gigli G; Fanin R
    Ann Hematol; 2001 Dec; 80(12):758-62. PubMed ID: 11797120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Light chain myeloma or the pitfalls of myeloma diagnosis].
    Zufferey P; Pugin P; Regamey C
    Schweiz Med Wochenschr; 1989 Jun; 119(22):791-5. PubMed ID: 2503870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central nervous system multiple myeloma--potential roles for intrathecal therapy and measurement of cerebrospinal fluid light chains.
    Lee D; Kalff A; Low M; Gangatharan S; Ho P; Bajel A; Ritchie D; Grigg A; Spencer A
    Br J Haematol; 2013 Aug; 162(3):371-5. PubMed ID: 23718539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the presence of lambda chain dimers in cerebrospinal fluid of patients suffering from subacute sclerosing panencephalitis.
    Riberi M; Bernard D; Depieds R
    Clin Exp Immunol; 1975 Jan; 19(1):45-53. PubMed ID: 812621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple myeloma invasion of the central nervous system.
    Schluterman KO; Fassas AB; Van Hemert RL; Harik SI
    Arch Neurol; 2004 Sep; 61(9):1423-9. PubMed ID: 15364689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical value of the blood measurement of the free light chains of immunoglobulins].
    Bidet A; Marit G; Bérard AM
    Ann Biol Clin (Paris); 2008; 66(4):427-31. PubMed ID: 18725344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Secondary liver involvement in multiple myeloma: diagnostic imaging with magnetic resonance tomography (MRI)].
    Ajaj W; Yang F; Ruehm SG
    Rofo; 2003 May; 175(5):706-7. PubMed ID: 12743867
    [No Abstract]   [Full Text] [Related]  

  • 9. The absence of CD56 on malignant plasma cells in the cerebrospinal fluid is the hallmark of multiple myeloma involving central nervous system.
    Chang H; Bartlett ES; Patterson B; Chen CI; Yi QL
    Br J Haematol; 2005 May; 129(4):539-41. PubMed ID: 15877737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of immunoglobulin content of CSF based on light chain characteristics.
    Eickhoff K; Heipertz R
    Ann Neurol; 1978 Jun; 3(6):509-12. PubMed ID: 98101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A comparative analysis of three diagnostic criteria for multiple myeloma].
    Lu J; Huang XJ
    Zhonghua Nei Ke Za Zhi; 2012 Feb; 51(2):114-6. PubMed ID: 22490811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic problem in a case of micromolecular myeloma].
    Pizzolato MA; Goñi FR; Reicherstorfer EV; Massot JE; de María HE; Burucúa JE
    Medicina (B Aires); 1979; 39(3):384-8. PubMed ID: 117277
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the serum free light chain (sFLC) analysis in prediction of response in symptomatic multiple myeloma patients: rapid profound reduction in involved FLC predicts achievement of VGPR.
    Hansen CT; Pedersen PT; Nielsen LC; Abildgaard N
    Eur J Haematol; 2014 Nov; 93(5):407-13. PubMed ID: 24809596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum test for assessment of patients with Bence Jones myeloma.
    Bradwell AR; Carr-Smith HD; Mead GP; Harvey TC; Drayson MT
    Lancet; 2003 Feb; 361(9356):489-91. PubMed ID: 12583950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Light-chain myeloma and non-secretory myeloma--problems in di- agnosis and associated paraproteins].
    Leinonen P; Somer T
    Duodecim; 1988; 104(18):1466-70. PubMed ID: 3141128
    [No Abstract]   [Full Text] [Related]  

  • 16. [A simple procedure for the reliable determination of free L-chains in the serum].
    Malberg K; Elendt D; Petermann B; Wutke K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(4):553-8. PubMed ID: 6170549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum free light chains for diagnosis and follow-up of multiple myeloma].
    Jung S; Kim M; Lim J; Kim Y; Han K; Min CK; Min WS
    Korean J Lab Med; 2008 Jun; 28(3):169-73. PubMed ID: 18594166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure.
    Hutchison CA; Plant T; Drayson M; Cockwell P; Kountouri M; Basnayake K; Harding S; Bradwell AR; Mead G
    BMC Nephrol; 2008 Sep; 9():11. PubMed ID: 18808676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolving use of serum free light chain assays in haematology.
    Pratt G
    Br J Haematol; 2008 May; 141(4):413-22. PubMed ID: 18318757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease.
    Kastritis E; Terpos E; Moulopoulos L; Spyropoulou-Vlachou M; Kanellias N; Eleftherakis-Papaiakovou E; Gkotzamanidou M; Migkou M; Gavriatopoulou M; Roussou M; Tasidou A; Dimopoulos MA
    Leukemia; 2013 Apr; 27(4):947-53. PubMed ID: 23183429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.